BioLineRx (BLRX) Property, Plant & Equipment (Net) Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34.64% |
| Sep 30, 2025 | -35.13% |
| Jun 30, 2025 | -34.06% |
| Mar 31, 2025 | -29.34% |
| Dec 31, 2024 | -26.63% |
| Sep 30, 2024 | -33.56% |
| Jun 30, 2024 | -30.00% |
| Mar 31, 2024 | -28.13% |
| Dec 31, 2023 | 41.97% |
| Sep 30, 2023 | -23.89% |
| Jun 30, 2023 | -22.50% |
| Mar 31, 2023 | -22.82% |
| Dec 31, 2022 | -17.03% |
| Sep 30, 2022 | -21.04% |
| Jun 30, 2022 | -19.94% |
| Mar 31, 2022 | -19.57% |
| Dec 31, 2021 | 107.08% |
| Sep 30, 2021 | -17.47% |
| Jun 30, 2021 | -16.33% |
| Mar 31, 2021 | -15.35% |
| Dec 31, 2020 | -6.94% |
| Sep 30, 2020 | -13.17% |
| Jun 30, 2020 | -8.69% |
| Mar 31, 2020 | 8.85% |
| Dec 31, 2019 | 76.84% |
| Sep 30, 2019 | 25.01% |
| Jun 30, 2019 | 24.73% |
| Mar 31, 2019 | 25.44% |
| Dec 31, 2018 | -35.10% |
| Sep 30, 2018 | 23.72% |
| Jun 30, 2018 | 23.93% |
| Mar 31, 2018 | 24.69% |
| Dec 31, 2017 | 16.78% |